New Delhi: It was a hallowed moment of pride for surgical robot SSI Mantra, its architect and robotic surgery wizard Dr Sudheer Srivastava, entire Indian Medtech Industry and ‘Make in India’ enthusiasts. As SS Innovations International rang the opening bell at NasdaqMarketSite in New York City, it asserted its ambition to march ahead for global conquest of operation theatres in no uncertain terms. At NASDAQ, company’s shares are listed under the ticker symbol ‘SSII’.
Installed in 80 hospitals across 75 locations in India, SSI Mantra has transcended borders to make its presence felt in overseas including countries namely Nepal, Ecuador, Guatemala, the Philippines, Indonesia, Sri Lanka,Colombia and Ukraine. Add to this, over 4,000 successful robotic surgeries completed across more than 100 surgical procedures. The ice on the cake is that ‘Made in India’ SSI Mantra is transforming access to advanced robotic surgery by offering it at a much deescalated cost making it affordable to all and sundry.
The opening bell ringing ceremony (on June 3) was led by Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations International, joined by members of the company’s management team, Board of Directors, key advisors and special guests. This milestone marked the proud moment for India cruising towards its transformation to Vikshit Bharat. The moment underscored nation’s growing leadership in advanced medical technologies and heralding a new era of innovation and international recognition for Indian-origin healthcare solutions.
With plans to expand into Europe and the United States, SS Innovations is positioning itself as a global leader in medical robotics, further solidifying India’s pivotal role in shaping the future of healthcare technology worldwide.
Expressing immense happiness and gratitude Dr. Sudhir Srivastava said, “Today’s opening bell-ringing ceremony marks a proud moment for all of us at SS Innovations International, commemorating our successful uplisting to Nasdaq in April2025. This milestone reflects relentless dedication of our team in developing the SSI Mantra, an advanced, cost-effective and world-class surgical robotic system designed and built in India. We are also celebrating the successful completion of over 4,000 robotic procedures across more than 100 types of surgeries, with zero complications, injuries or mortalities, which is a testament to the system’s precision and safety.”
Dr Srivastava further added saying, “ The SSI Mantra is now gaining strong traction among surgeons not just across India but also in six other countries, and we are actively working to expand into key global markets, including the European Union and the United States. Our mission remains clear: to make cutting-edge robotic surgery accessible and affordable for patients worldwide, with India at the forefront.”
SS Innovations International has reported impressive financial growth for the year ending December31,2024, with revenues reaching $20.6million—a3.5-foldincrease from the previous year’s revenue of $5.9 million. Gross margins also showed significant improvement, rising to 40.9% from 12.3% in 2023, highlighting the company’s robust financial performance and expanding market presence.
